Molecular and Integrative Physiology, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Pediatrics, Section of Nutrition, The University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Function (Oxf). 2021 Jan 22;2(2):zqab001. doi: 10.1093/function/zqab001. eCollection 2021.
Nonacholic fatty liver disease, or hepatic steatosis, is the most common liver disorder affecting the western world and currently has no pharmacologic cure. Thus, many investigations have focused on alternative strategies to treat or prevent hepatic steatosis. Our laboratory has shown that chronic heat treatment (HT) mitigates glucose intolerance, insulin resistance, and hepatic steatosis in rodent models of obesity. Here, we investigate the direct bioenergetic mechanism(s) surrounding the metabolic effects of HT on hepatic mitochondria. Utilizing mitochondrial proteomics and respiratory function assays, we show that one bout of acute HT (42°C for 20 min) in male C57Bl/6J mice ( = 6/group) triggers a hepatic mitochondrial heat shock response resulting in acute reductions in respiratory capacity, degradation of key mitochondrial enzymes, and induction of mitophagy via mitochondrial ubiquitination. We also show that chronic bouts of HT and recurrent activation of the heat shock response enhances mitochondrial quality and respiratory function via compensatory adaptations in mitochondrial organization, gene expression, and transport even during 4 weeks of high-fat feeding ( = 6/group). Finally, utilizing a liver-specific heat shock protein 72 (HSP72) knockout model, we are the first to show that HSP72, a protein putatively driving the HT metabolic response, does not play a significant role in the hepatic mitochondrial adaptation to acute or chronic HT. However, HSP72 is required for the reductions in blood glucose observed with chronic HT. Our data are the first to suggest that chronic HT (1) improves hepatic mitochondrial respiratory efficiency via mitochondrial remodeling and (2) reduces blood glucose in a hepatic HSP72-dependent manner.
非酒精性脂肪肝疾病,或肝脂肪变性,是影响西方世界的最常见肝脏疾病,目前尚无药物治愈方法。因此,许多研究都集中在治疗或预防肝脂肪变性的替代策略上。我们的实验室已经表明,慢性热疗(HT)可以减轻肥胖啮齿动物模型的葡萄糖不耐受、胰岛素抵抗和肝脂肪变性。在这里,我们研究了 HT 对肝线粒体代谢影响的直接生物能学机制。利用线粒体蛋白质组学和呼吸功能测定,我们表明,单次急性 HT(42°C 20 分钟)在雄性 C57Bl/6J 小鼠中(每组 = 6)触发肝线粒体热休克反应,导致呼吸能力急性下降、关键线粒体酶降解以及线粒体泛素化诱导的线粒体自噬。我们还表明,慢性 HT 发作和反复激活热休克反应通过增强线粒体质量和呼吸功能来增强线粒体质量和呼吸功能,即使在 4 周高脂肪喂养期间(每组 = 6)也通过线粒体组织、基因表达和运输的代偿适应来实现。最后,利用肝脏特异性热休克蛋白 72(HSP72)敲除模型,我们首次表明 HSP72,一种假定驱动 HT 代谢反应的蛋白质,在急性或慢性 HT 适应肝线粒体中没有发挥重要作用。然而,HSP72 是慢性 HT 观察到的血糖降低所必需的。我们的数据首次表明,慢性 HT(1)通过线粒体重塑提高肝线粒体呼吸效率,(2)以 HSP72 依赖的方式降低血糖。